BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 18931615)

  • 1. Estrogen receptor beta (ERbeta) in endometrial simple hyperplasia and endometrioid carcinoma.
    Chakravarty D; Srinivasan R; Ghosh S; Rajwanshi A; Gopalan S
    Appl Immunohistochem Mol Morphol; 2008 Dec; 16(6):535-42. PubMed ID: 18931615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor beta1 and the beta2/betacx isoforms in nonneoplastic endometrium and in endometrioid carcinoma.
    Chakravarty D; Srinivasan R; Ghosh S; Gopalan S; Rajwanshi A; Majumdar S
    Int J Gynecol Cancer; 2007; 17(4):905-13. PubMed ID: 17309672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of gonadal steroid receptors in the ovaries of post-menopausal women with malignant or benign endometrial pathology: a pilot study.
    Panoulis K; Christantoni E; Pliatsika P; Anagnostis P; Goulis DG; Kondi-Pafiti A; Armeni E; Augoulea A; Triantafyllou N; Creatsa M; Lambrinoudaki I
    Gynecol Endocrinol; 2015; 31(8):613-7. PubMed ID: 26036714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of estrogen receptor α and β in the regulation of proliferation in endometrial carcinoma.
    Hu G; Zhang J; Zhou X; Liu J; Wang Q; Zhang B
    Pathol Res Pract; 2020 Oct; 216(10):153149. PubMed ID: 32853964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL ADENOCARCINOMA.
    Socolov D; Socolov R; Lupascu IA; Rugina V; Gabia O; Garauleanu DM; Carauleanu A
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):355-62. PubMed ID: 27483717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered expression of ERs, aromatase, and COX2 connected to estrogen action in type 1 endometrial cancer biology.
    Jarzabek K; Koda M; Walentowicz-Sadlecka M; Grabiec M; Laudanski P; Wolczynski S
    Tumour Biol; 2013 Dec; 34(6):4007-16. PubMed ID: 23873111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in expression of estrogen receptors alpha and beta in relation to progesterone receptor and pS2 status in normal and malignant endometrium.
    Saegusa M; Okayasu I
    Jpn J Cancer Res; 2000 May; 91(5):510-8. PubMed ID: 10835496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas.
    Wu W; Slomovitz BM; Celestino J; Chung L; Thornton A; Lu KH
    Cancer Res; 2003 Oct; 63(19):6195-9. PubMed ID: 14559803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated macrophages correlate with progesterone receptor loss in endometrial endometrioid adenocarcinoma.
    Jiang XF; Tang QL; Li HG; Shen XM; Luo X; Wang XY; Lin ZQ
    J Obstet Gynaecol Res; 2013 Apr; 39(4):855-63. PubMed ID: 23106983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
    Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
    Lax SF; Pizer ES; Ronnett BM; Kurman RJ
    Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2): a novel biomarker for the identification of atypical hyperplasia and Type I endometrial carcinoma.
    Buell-Gutbrod R; Cavallo A; Lee N; Montag A; Gwin K
    Int J Gynecol Pathol; 2015 Jan; 34(1):65-73. PubMed ID: 25473755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of c-myc, c-jun and estrogen receptor in normal, hyperplastic and neoplastic endometrium.
    Bircan S; Ensari A; Ozturk S; Erdogan N; Dundar I; Ortac F
    Pathol Oncol Res; 2005; 11(1):32-9. PubMed ID: 15800680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of tumor suppressor gene product p14ARF in endometrioid adenocarcinoma of the uterine corpus.
    Watanabe J; Nishizaki R; Jobo T; Kamata Y; Hata H; Nishimura Y; Fujisawa T; Okayasu I; Kuramoto H
    Int J Gynecol Pathol; 2004 Jul; 23(3):234-40. PubMed ID: 15213599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of receptor-binding cancer antigen expressed on SiSo cells and estrogen receptor subtypes in the normal, hyperplastic, and carcinomatous endometrium.
    Zhou XH; Teng XD; Song WY; Wu YJ
    Int J Gynecol Cancer; 2008; 18(1):152-8. PubMed ID: 17466050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-type amino acid transporter 1 expression increases in well-differentiated but decreases in poorly differentiated endometrial endometrioid adenocarcinoma and shows an inverse correlation with p53 expression.
    Watanabe J; Yokoyama Y; Futagami M; Mizunuma H; Yoshioka H; Washiya K; Hana K; Endou H; Okayasu I
    Int J Gynecol Cancer; 2014 May; 24(4):659-63. PubMed ID: 24694899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of estrogen receptors ERalpha and ERbeta in endometrial hyperplasia and adenocarcinoma.
    Hu K; Zhong G; He F
    Int J Gynecol Cancer; 2005; 15(3):537-41. PubMed ID: 15882182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1 system and sex steroid receptor gene expression in human endometrial cancer.
    Singer CF; Kronsteiner N; Marton E; Walter I; Kubista M; Czerwenka K; Schreiber M; Tschugguel W; Wieser F; Kubista E
    Gynecol Oncol; 2002 Jun; 85(3):423-30. PubMed ID: 12051868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular retinol binding protein-1 expression in endometrial hyperplasia and carcinoma: diagnostic and possible therapeutic implications.
    Orlandi A; Ferlosio A; Ciucci A; Francesconi A; Lifschitz-Mercer B; Gabbiani G; Spagnoli LG; Czernobilsky B
    Mod Pathol; 2006 Jun; 19(6):797-803. PubMed ID: 16575402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of beta-catenin, Glut-1, PTEN proteins in uterine endometrioid adenocarcinoma and its precursor lesions].
    Xiong Y; Xiong YY; Zhou YF
    Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):594-9. PubMed ID: 20079187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.